{
    "eid": "2-s2.0-85116661735",
    "title": "Targets and strategies for vaccine development against dengue viruses",
    "cover-date": "2021-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Dengue vaccine",
        "Dengue virus",
        "DNA vaccine",
        "Inactivated virus",
        "Live-attenuated virus",
        "Review",
        "Subunit vaccine",
        "Viral-vector vaccine"
    ],
    "authors": [
        "Wen Hung Wang",
        "Aspiro Nayim Urbina",
        "Chih Yen Lin",
        "Zih Syuan Yang",
        "Wanchai Assavalapsakul",
        "Arunee Thitithanyanont",
        "Po Liang Lu",
        "Yen Hsu Chen",
        "Sheng Fan Wang"
    ],
    "citedby-count": 7,
    "ref-count": 168,
    "ref-list": [
        "Dengue",
        "The global distribution and burden of dengue",
        "Refining the global spatial limits of dengue virus transmission by evidence-based consensus",
        "Research on dengue during World War II",
        "Dengue hemorrhagic fever \u2013 a systemic literature review of current perspectives on pathogenesis, prevention and control",
        "Analyses of clinical and laboratory characteristics of dengue adults at their hospital presentations based on the World Health Organization clinical-phase framework: emphasizing risk of severe dengue in the elderly",
        "Antibody-dependent enhancement of severe dengue disease in humans",
        "Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes",
        "Cross-reacting antibodies enhance dengue virus infection in humans",
        "Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors",
        "The complexity of antibody-dependent enhancement of dengue virus infection",
        "Structure of dengue virus: implications for flavivirus organization, maturation, and fusion",
        "Properties and functions of the dengue virus capsid protein",
        "Atomic-level functional model of dengue virus Envelope protein infectivity",
        "Structure of the immature dengue virus at low pH primes proteolytic maturation",
        "Structural proteomics of dengue virus",
        "The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry",
        "Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion",
        "Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics",
        "Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate",
        "Re-evaluation of the pathogenic roles of nonstructural protein 1 and its antibodies during dengue virus infection",
        "Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections",
        "High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever",
        "An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients",
        "Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity",
        "Dengue virus NS1 protein activates immune cells via TLR4 but not TLR2 or TLR6",
        "Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components",
        "Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity",
        "Induction of a protective response in mice by the dengue virus NS3 protein using DNA vaccines",
        "Poian, Receptors and routes of dengue virus entry into the host cells",
        "Dengue virus infection is through a cooperative interaction between a mannose receptor and CLEC5A on macrophage as a multivalent hetero-complex",
        "Dengue vaccine development by the year 2020: challenges and prospects",
        "Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement",
        "A structural perspective of the flavivirus life cycle",
        "A ligand-binding pocket in the dengue virus envelope glycoprotein",
        "Visualization of membrane protein domains by cryo-electron microscopy of dengue virus",
        "Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes",
        "Alternative infectious entry pathways for dengue virus serotypes into mammalian cells",
        "Progress in the identification of dengue virus entry/fusion inhibitors",
        "An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells",
        "Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate",
        "Characterization of the interaction of domain III of the envelope protein of dengue virus with putative receptors from CHO cells",
        "Contribution of disulfide bridging to epitope expression of the dengue type 2 virus envelope glycoprotein",
        "Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells",
        "Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding",
        "Adaptive immune responses to primary and secondary dengue virus infections",
        "The human antibody response to dengue virus infection",
        "Protective capacity of the human anamnestic antibody response during acute dengue virus infection",
        "Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms",
        "Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus",
        "Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins",
        "Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine",
        "Dengue E protein domain III-Based DNA immunisation induces strong antibody responses to all four viral serotypes",
        "The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker",
        "Flavivirus NS1: a multifaceted enigmatic viral protein",
        "The dual role of the antibody response against the flavivirus non-structural protein 1 (NS1) in protection and immuno-pathogenesis",
        "Dengue virus non-structural protein 1 modulates infectious particle production via interaction with the structural proteins",
        "The dengue virus non-structural protein 1 (NS1) is secreted efficiently from infected mosquito cells",
        "The dengue virus non-structural protein 1 (NS1) is secreted from infected mosquito cells via a non-classical caveolin-1-dependent pathway",
        "Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system",
        "The dengue virus nonstructural protein 1 (NS1) is secreted from mosquito cells in association with the intracellular cholesterol transporter chaperone caveolin complex",
        "Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein",
        "The secreted form of dengue virus nonstructural protein NS1 is endocytosed by hepatocytes and accumulates in late endosomes: implications for viral infectivity",
        "Structure-guided insights on the role of NS1 in flavivirus infection",
        "Structural basis of Flavivirus NS1 assembly and antibody recognition",
        "Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement",
        "Determination of viremia and concentration of circulating nonstructural protein 1 in patients infected with dengue virus in Mexico",
        "Efficacy and long-term safety of a dengue vaccine in regions of endemic disease",
        "Antibody-dependent enhancement: a challenge for developing a safe dengue vaccine",
        "Secretion of flaviviral non-structural protein NS1: from diagnosis to pathogenesis",
        "Aspects of T cell-mediated immunity induced in mice by a DNA vaccine based on the dengue-NS1 antigen after challenge by the intracerebral route",
        "Cooperation between CD4+ T cells and humoral immunity is critical for protection against dengue using a DNA vaccine based on the NS1 antigen",
        "Molecular mimicry between virus and host and its implications for dengue disease pathogenesis",
        "Dengue virus nonstructural protein 1-induced antibodies cross-react with human plasminogen and enhance its activation",
        "The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis",
        "Antibodies against modified NS1 wing domain peptide protect against dengue virus infection",
        "Flavivirus NS1 and its potential in vaccine development",
        "Cause of an outbreak of encephalitis established by means of complement-fixation tests",
        "Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48",
        "Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1",
        "Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1",
        "Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection",
        "Characterization of neutralizing epitopes in antigenic site B of recently circulating influenza A(H3N2) viruses",
        "Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice",
        "A plasmid encoding parts of the dengue virus E and NS1 proteins induces an immune response in a mouse model",
        "Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence",
        "Expression of dengue virus structural proteins and nonstructural protein NS1 by a recombinant vaccinia virus",
        "Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis",
        "Immunoreactivity and protective effects in mice of a recombinant dengue 2 Tonga virus NS1 protein produced in a baculovirus expression system",
        "Immunization of monkeys with baculovirus-dengue type-4 recombinants containing envelope and nonstructural proteins: evidence of priming and partial protection",
        "Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis",
        "Deglycosylation of the NS1 protein of dengue 2 virus, strain 16681: construction and characterization of mutant viruses",
        "Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever",
        "Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5\u2019 noncoding region and nonstructural proteins 1 and 3",
        "A non-structural 1 protein G53D substitution attenuates a clinically tested live dengue vaccine",
        "A T164S mutation in the dengue virus NS1 protein is associated with greater disease severity in mice",
        "Recent developments in recombinant protein-based dengue vaccines",
        "Towards development of a universal dengue vaccine - how close are we?",
        "Efficient delivery of dengue virus subunit vaccines to the skin by microprojection arrays",
        "Short report: antibody responses of mice immunized with a tetravalent dengue recombinant protein subunit vaccine",
        "Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells",
        "Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice",
        "Eliciting cross-neutralizing antibodies in mice challenged with a dengue virus envelope domain III expressed in Escherichia coli",
        "Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity",
        "Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice",
        "Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice",
        "A tetravalent dengue vaccine containing a mix of domain III-P64k and domain III-capsid proteins induces a protective response in mice",
        "Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virus",
        "Induction of neutralizing antibodies against four serotypes of dengue viruses by MixBiEDIII, a tetravalent dengue vaccine",
        "Elaboration of tetravalent antibody responses against dengue viruses using a subunit vaccine comprised of a single consensus dengue envelope sequence",
        "Comparative immunogenicity of preparations of yeast-derived dengue oral vaccine candidate",
        "Preclinical development of a dengue tetravalent recombinant subunit vaccine: immunogenicity and protective efficacy in nonhuman primates",
        "Complexity of neutralizing antibodies against multiple dengue virus serotypes after heterotypic immunization and secondary infection revealed by in-depth analysis of cross-reactive antibodies",
        "Comparison of purified psoralen-inactivated and formalin-inactivated dengue vaccines in mice and nonhuman primates",
        "Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys",
        "Immunogenic and protective response in mice immunized with a purified, inactivated, Dengue-2 virus vaccine prototype made in fetal rhesus lung cells",
        "An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model",
        "Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy",
        "Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination",
        "Phase 1 randomized study of a tetravalent dengue purified inactivated vaccine in healthy adults in the United States",
        "Phase I randomized study of a tetravalent dengue purified inactivated vaccine in healthy adults from Puerto Rico",
        "Safety and immunogenicity of an AS03B-adjuvanted inactivated tetravalent dengue virus vaccine administered on varying schedules to healthy U.S. adults: a phase 1/2 randomized study",
        "Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial",
        "Efficacy of a tetravalent dengue vaccine in children in Latin America",
        "Effect of dengue serostatus on dengue vaccine safety and efficacy",
        "Immune response persistence and safety of a booster dose of the tetravalent dengue vaccine in adolescents and adults who previously completed the 3-dose schedule 4-5 years earlier in Latin America: a randomized placebo-controlled trial",
        "Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaques",
        "Dengue virus NS1 disrupts the endothelial glycocalyx, leading to hyperpermeability",
        "Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial",
        "Efficacy of a tetravalent dengue vaccine in healthy children and adolescents",
        "Historical discourse on the development of the live attenuated tetravalent dengue vaccine candidate TV003/TV005",
        "Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD vaccine?",
        "Robust and balanced immune responses to all 4 dengue virus serotypes following administration of a single dose of a live attenuated tetravalent dengue vaccine to healthy, flavivirus-naive adults",
        "A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial",
        "A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans",
        "Development of dengue DNA vaccines",
        "Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice",
        "Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein",
        "A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys",
        "Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial",
        "Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses",
        "Characterization of antibody responses to combinations of a dengue-2 DNA and dengue-2 recombinant subunit vaccine",
        "Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein vaccines in rhesus macaques",
        "Safety and immunogenicity of a tetravalent dengue DNA vaccine administered with a cationic lipid-based adjuvant in a phase 1 clinical trial",
        "Dengue virus vaccine development",
        "Review of dengue virus and the development of a vaccine",
        "Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice",
        "Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge",
        "Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses",
        "A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus",
        "Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration",
        "An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection",
        "A heterologous DNA prime-Venezuelan equine encephalitis virus replicon particle boost dengue vaccine regimen affords complete protection from virus challenge in cynomolgus macaques",
        "A tetravalent alphavirus-vector based dengue vaccine provides effective immunity in an early life mouse model",
        "Prospects for a dengue virus vaccine",
        "Critical issues in dengue vaccine development",
        "Dengue virus infection with highly neutralizing levels of cross-reactive antibodies causes acute lethal small intestinal pathology without a high level of viremia in mice",
        "Cross-reactive memory CD8(+) T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner",
        "Animal models for dengue vaccine development and testing",
        "Protection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1",
        "XAF1 contributes to dengue virus-induced apoptosis in vascular endothelial cells",
        "Correlation between serum levels of anti-endothelial cell autoantigen and anti-dengue virus nonstructural protein 1 antibodies in dengue patients",
        "Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1",
        "Vaccines and immunization strategies for dengue prevention",
        "Transmission-blocking antibodies against mosquito C-type lectins for dengue prevention",
        "Dengue virus infection of aedes aegypti requires a putative cysteine rich venom protein"
    ],
    "affiliation": [
        {
            "affiliation-city": "Kaohsiung",
            "@id": "60073387",
            "affilname": "Kaohsiung Medical University Chung-Ho Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073387",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Kaohsiung",
            "@id": "60012256",
            "affilname": "Kaohsiung Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012256",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Ministry of Science and Technology",
        "Kaohsiung Medical University"
    ]
}